Market Report

Market Report by Email

If you would like to receive the daily Market Report by email please fill out your name and email address in the sign-up form below and you will be added to our mailing list.

* indicates required

Please select all the ways you would like to hear from Ramsey Crookall:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our email marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing.

Learn more about Mailchimp's privacy practices here.

Friday,02 August 2024 at 15:07

European equities plunged again as part of the global selloff in sharemarkets continued on Friday, after weak US manufacturing data sparked fears of the world's biggest economy going into recession, while chipmakers were hit hard by Intel suspended its dividend and announced plans to slash its workforce.

London stocks were still in the red by mid afternoon on Friday as weak US data raised fears about the economy, and ahead of the release of the all-important non-farm payrolls report.

Wall Street stocks were firmly in the red at the opening bell on Friday amid resurgent fears of a potentially oncoming recession.

The U.S. dollar dropped after data on Friday showed that employers added fewer jobs in July than economists had forecast, while the unemployment rate unexpectedly moved higher.

Gold prices hit their highest in over two weeks on Friday as Treasury yields and the dollar declined after data showed the U.S. economy created fewer jobs than expected in July, boosting hopes of rate cuts by the Federal Reserve this year.

U.S. crude oil fell nearly 3% on Friday, after a weak jobs report raised renewed fears that a recession could be on the horizon.

GSK was in the black as it said the US Food and Drug Administration has approved its Jemperli treatment in combination with chemotherapy and then use on its own for adult patients with primary advanced or recurrent endometrial cancer.

 

Markets
16:05
FTSE 100 8,164 (-1.44%)
FTSE 250 20,817 (-2.99%)
DAX 17,707 (-2.08%)
16:05
Dow Jones 39,450.17 (-2.23%)
S&P 500 5,306 (-2.58%)
NASDAQ 16,660 (-3.11%)
Fixed Income
UK 10-YR YIELD 3.846
Exchange Rates
GBP/USD 1.2808
GBP/EUR 1.1725
Commodities
Gold $2,431 (-0.57%)
Brent $76.92 (-3.78%)
Important - No news or research item should be construed as a recommendation to trade. The inclusion of securities within this report does not necessarily imply their suitability for individual portfolios or situations in respect of which further advice should be sought. Information contained in this report has been compiled from sources believed to be reliable but is not warranted to be accurate or complete.

We use cookies to improve your experience on our website.
By continuing to browse, you agree to our use of cookies. Cookie Policy

Accept
Members of the London Stock Exchange and PIMFA | Licensed by the Isle of Man Financial Services Authority (IoMFSA) Registered Office: Ramsey Crookall and Co. Ltd., 38/42 Athol Street, Douglas, Isle of Man, IM1 1QH
Copyright © 2023 - Ramsey Crookall & Co. Ltd
Building Personal Finance Futures London Stock Exchange